Health System

Patients with Parkinson disease who participated in weekly dance training with music exhibited no decline in motor function and motor or nonmotor experiences of daily living across a 3-year span.

The new standards come as community oncology practices await word on the future of the oncology care model, which will expire in 2022.

HHS officials say that fully vaccinated individuals do not need to get a booster shot; FDA issues a warning on link between the Johnson & Johnson vaccine and a rare neurological condition; California counties sue pesticide manufacturer over widely used bug killer that may cause brain damage in children and fetuses.

The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.

This episode of Managed Care Cast features interviews with experts who discuss how the same efforts to stamp out COVID-19 also reduced Clostridioides difficile and the prospects for such mitigation efforts to continue.

Robin Gelburd, JD, details the dip in telehealth claims observed during April 2021.

The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.

Ambulance response services in rural communities face increasing recruitment and expense burdens; data from Israel show a decline in Pfizer/BioNTech COVID-19 vaccine efficacy in preventing symptomatic SARS-CoV-2 infection; the US Supreme Court will hear a case on 340B drug payment cuts.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist at Geisinger, discusses biologic, lifestyle, and pandemic-related factors associated with poor sleep quality in adolescents.

Health insurance companies are anticipating a swell in pent-up demand for delayed or forgone health services in 2020, as well as increased costs associated with distributing COVID-19 vaccines to millions of Americans. To offset the potentially precarious business impact caused by these converging factors, insurers are turning to technology for help.

Roundtable discussions between health care purchasers and physician practices highlight their aligned interest in having patients managed by a primary care physician, with other topics such as behavioral health, social determinants of health, and telehealth referenced as well.

A pharmacist-led collaborative medication management service reduced problems associated with polypharmacy in older adults with chronic kidney disease (CKD).

Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ever to address uncontrolled asthma head-on.

The measure is designed to end surprise medical billing and balance billing, taking the first step to implement the so-called No Surprises Act that passed Congress at the end of last year.

With systemic health and social inequalities contributing to a lack of health care access and a growing mortality risk among rural Americans, the COVID-19 pandemic has further exacerbated health issues present between community lines. We spotlight several health challenges in these communities and potential solutions to improve the general health of rural populations.

House of Representatives passes 2 pieces of legislation to boost funding in scientific research; Juul agrees to pay $40 million settlement to North Carolina for its role in the teen vaping epidemic; LA County Department of Public Health recommends for all residents to wear masks in public indoor places amid Delta variant concerns.

Patients worldwide are reluctant to visit clinics and hospitals amid fears of COVID-19. Implementing virtual care capabilities can not only relieve the patients of this fear by minimizing in-person exposure and preventing the virus from spreading, but also improve patient-centered care delivery.

Health experts call for the FDA to move faster in fully approving COVID-19 vaccines to combat hesitancy; long-term effects of COVID-19 may impact risk of complications when undergoing elective surgeries; Johnson & Johnson (J&J) agrees to a $230 million opioid settlement with the state of New York.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Updates reflect the increased intersection among diabetes, cardiovascular, and kidney disease care among certain drug classes, especially sodium glucose co-transporter 2 (SGLT2) inhibitors.

The head of AHIP sat down with a senator and 3 health care executives for a conversation about payment and access issues at the organization's 2021 Institute and Expo Online.

The average US life expectancy decreased by nearly 2 years from 2018 to 2020, with minority groups affected the most; the FDA will add a rare heart inflammation warning to fact sheets for the Pfizer and Moderna COVID-19 vaccines; a series of expansions to the Medicaid safety-net program is reportedly in consideration.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

At a session of AHIP 2021 Institute and Expo Online, the head of North Carolina's health and human services department and a health equity policy advisor in the Biden administration discussed how collecting and using data to achieve health equity is ultimately a policy decision.

Christopher Arendt, PhD, head of the Oncology Therapeutic Area Unit at Takeda, discusses pathogenesis and characteristics of EGFR exon 20 mutations in metastatic non–small cell lung cancer (NSCLC).

A report from Xcenda showed that biosimilars for 8 blockbuster reference biologics have successfully kept drug prices from increasing by an average of 56%, restoring the possibility that biosimilars could achieve significant discounts despite facing several barriers to uptake.

Agility has long been a big buzzword, but its salience and importance has been growing. Gallup’s research on agility finds that there are 7 fundamental shifts common to highly agile leaders—driving these changes through a hospital can help significantly advance a culture of agility.